Cargando…

Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release

Introduction: Multiple myeloma (MM) is characterized by a high prevalence of thrombotic complications. Microvesicles (MVs) are small membrane vesicles released from activated cells, and they may potentially contribute to thrombosis. Methods: We have evaluated the plasma levels of MVs and cytokines (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gidaro, Antonio, Manetti, Roberto, Delitala, Alessandro Palmerio, Soloski, Mark Johns, Lambertenghi Deliliers, Giorgio, Castro, Dante, Soldini, Davide, Castelli, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143530/ https://www.ncbi.nlm.nih.gov/pubmed/35628848 http://dx.doi.org/10.3390/jcm11102720

Ejemplares similares

Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia
por: Gidaro, Antonio, et al.
Publicado: (2022)

Bendamustine and Rituximab, as First Line Treatment, in Intermediate, High Risk Splenic Marginal Zone Lymphomas of Elderly Patients
por: Castelli, Roberto, et al.
Publicado: (2016)

Prothrombotic and Inflammatory Markers in Elderly Patients with Non-Alcoholic Hepatic Liver Disease before and after Weight Loss: A Pilot Study
por: Gidaro, Antonio, et al.
Publicado: (2021)

Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015)

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
por: Ramberg, Cathrine, et al.
Publicado: (2021)

A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review
por: Gidaro, Antonio, et al.
Publicado: (2022)

Impact of Epicatechin on the Procoagulant Activities of Microparticles
por: Sinegre, Thomas, et al.
Publicado: (2020)

Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review
por: Profili, Nicia I., et al.
Publicado: (2023)

Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection
por: Castelli, Roberto, et al.
Publicado: (2020)

Procoagulant Microparticles in Dogs with Immune‐Mediated Hemolytic Anemia
por: Kidd, L., et al.
Publicado: (2015)

MPs-ACT, an Assay to Evaluate the Procoagulant Activity of Microparticles
por: Gao, Yalong, et al.
Publicado: (2023)

Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis
por: Marchandot, Benjamin, et al.
Publicado: (2021)

Circulating Endothelial Cells and Procoagulant Microparticles in Patients with Glioblastoma: Prognostic Value
por: Reynés, Gaspar, et al.
Publicado: (2013)

Effects of Cryopreservation on Microparticles Concentration, Procoagulant Function, Size Distribution, and Morphology
por: Dong, Xinlong, et al.
Publicado: (2019)

Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer
por: Haghbeen, Marzieh, et al.
Publicado: (2021)

An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2008)

Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients
por: Zhao, Liangliang, et al.
Publicado: (2016)

Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes
por: Zhang, Chenghui, et al.
Publicado: (2019)

Elevated Procoagulant Endothelial and Tissue Factor Expressing Microparticles in Women with Recurrent Pregnancy Loss
por: Patil, Rucha, et al.
Publicado: (2013)

Procoagulant factor levels and risk of venous thrombosis in the elderly
por: Wang, Huijie, et al.
Publicado: (2020)

Venous thromboembolism in multiple myeloma is associated with increased mortality
por: Schoen, Martin W., et al.
Publicado: (2020)

Aging of the Arterial System
por: Castelli, Roberto, et al.
Publicado: (2023)

Inter-Relationship between Platelet-Derived Microparticles and Oxidative Stress in Patients with Venous Thromboembolism
por: Signorelli, Salvatore Santo, et al.
Publicado: (2020)

The Exposure of Phosphatidylserine Influences Procoagulant Activity in Retinal Vein Occlusion by Microparticles, Blood Cells, and Endothelium
por: Su, Ying, et al.
Publicado: (2018)

P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS
por: Wang, Y., et al.
Publicado: (2022)

Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer
por: Kobayashi, Satoshi, et al.
Publicado: (2021)

Elevated levels of procoagulant microparticles in a patient with myocardial infarction, antiphospholipid antibodies and multifocal cardiac thrombosis
por: Morel, O, et al.
Publicado: (2005)

Procoagulant, Tissue Factor-Bearing Microparticles in Bronchoalveolar Lavage of Interstitial Lung Disease Patients: An Observational Study
por: Novelli, Federica, et al.
Publicado: (2014)

Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma
por: Nielsen, Thøger, et al.
Publicado: (2019)

Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients
por: Barrett, Aisling, et al.
Publicado: (2021)

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
por: Sanfilippo, Kristen M., et al.
Publicado: (2022)

Nursing management of treatment-related venous thromboembolism in patients with multiple myeloma
por: Yang, Bianhong, et al.
Publicado: (2023)

P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA
por: Alp Kirkizlar, Tugcan, et al.
Publicado: (2023)

Procoagulant activity of circulating microparticles is associated with the presence of moderate calcified plaque burden detected by multislice computed tomography
por: Del Turco, Serena, et al.
Publicado: (2014)

Indolic Uremic Solutes Enhance Procoagulant Activity of Red Blood Cells through Phosphatidylserine Exposure and Microparticle Release
por: Gao, Chunyan, et al.
Publicado: (2015)

P1668: NON-APOPTOTIC CIRCULATING MICROPARTICLES ARE INVERSELY ASSOCIATED WITH PROCOAGULANT BIOMARKERS IN PATIENTS WITH ACUTE CORONARY SYNDROMES
por: Pallantza, Zoi, et al.
Publicado: (2023)

Phenotypic heterogeneity of latent autoimmune diabetes in adults identified by body composition analysis
por: Pes, Giovanni Mario, et al.
Publicado: (2014)

Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis
por: Mendoza, Carmen E., et al.
Publicado: (2019)

Prophylaxis of Venous Thromboembolism in Ankle and Foot Surgeries
por: Zambelli, Roberto, et al.
Publicado: (2020)

Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma
por: Brown, Joshua D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f5f9g5a8fg3qlisf199e39t2ds